34 / 242
34
Chapter 3
Table 3.
Baseline characteristics (n=178)
Age (y)
80.4 ± 7.2
BMI (kg/m2)
29 ± 5.9
Clinical history
Hypertension
104 (58%)
Diabetes
52 (29%)
Hypercholesterolemia
47 (26%)
Prior myocardial infarction
32 (18%)
Prior PCI
58 (33%)
Prior CABG
23 (13%)
Prior stroke
29 (16%)
Peripheral arterial disease
37 (21%)
COPD
56 (31%)
Renal insufficiency
74 (42%)
Liver cirrhosis
2 (1%)
Prior neoplasia
39 (22%)
Atrial fibrillation
39 (22%)
Prior pacemaker
21 (12%)
NYHA class ≥ 3
105 (59%)
Preprocedural hospitalisation
46 (26%)
Logistic EuroSCORE
19 ± 12.7
STS score
6.2 ± 5.2
Preprocedural variables
LVEF ≤ 40%
25 (14%)
AVA (cm2)
0.76 ± 0.24
Indexed EOA (cm2/m2)
0.41 ± 0.13
AVPG max (mmHg)
70.6 ± 23.6
AVPG mean (mmHg)
45 ± 15.4
Annulus diameter (mm)
21 ± 1.4
AR grade ≥ 2
30 (17%)
MR grade ≥ 3
22 (12%)
TR grade ≥ 2
56 (32%)
PAP (mmHg)
40 ± 17.3
Data expressed as mean ± SD or number (percentage). BMI, body mass index; PCI, percutaneous coronary
intervention; CABG, coronary artery bypass graft; COPD, chronic obstructive pulmonary disease; NYHA, New York
Heart Association; STS, society of thoracic surgeons; LVEF, left ventricular ejection fraction; AVA, aortic valve area;
AVPG, aortic valve pressure gradient; AR, aortic regurgitation; MR, mitral regurgitation; TR, tricuspid regurgitation;
PAP, pulmonary artery pressure